152 related articles for article (PubMed ID: 1581534)
1. In vivo detection and characterization of protein adducts resulting from bioactivation of haloethene cysteine S-conjugates by 19F NMR: chlorotrifluoroethene and tetrafluoroethene.
Harris JW; Dekant W; Anders MW
Chem Res Toxicol; 1992; 5(1):34-41. PubMed ID: 1581534
[TBL] [Abstract][Full Text] [Related]
2. Formation, characterization, and immunoreactivity of lysine thioamide adducts from fluorinated nephrotoxic cysteine conjugates in vitro and in vivo.
Fisher MB; Hayden PJ; Bruschi SA; Dulik DM; Yang Y; Ward AJ; Stevens JL
Chem Res Toxicol; 1993; 6(2):223-30. PubMed ID: 8477013
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity of S-(2-chloro-1,1,2-trifluoroethyl)glutathione and S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine, the glutathione and cysteine conjugates of chlorotrifluoroethene.
Dohn DR; Leininger JR; Lash LH; Quebbemann AJ; Anders MW
J Pharmacol Exp Ther; 1985 Dec; 235(3):851-7. PubMed ID: 4078735
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of [2-3H-ethyl]S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine and its use in covalent-binding studies.
Harris JW; Fitzsimmons ME; Anders MW
Anal Biochem; 1992 Aug; 204(2):300-4. PubMed ID: 1443527
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation mechanism of the cytotoxic and nephrotoxic S-conjugate S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine.
Dekant W; Lash LH; Anders MW
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7443-7. PubMed ID: 3478703
[TBL] [Abstract][Full Text] [Related]
6. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A).
Iyer RA; Anders MW
Chem Res Toxicol; 1997 Jul; 10(7):811-9. PubMed ID: 9250416
[TBL] [Abstract][Full Text] [Related]
7. Formation of mitochondrial phospholipid adducts by nephrotoxic cysteine conjugate metabolites.
Hayden PJ; Welsh CJ; Yang Y; Schaefer WH; Ward AJ; Stevens JL
Chem Res Toxicol; 1992; 5(2):232-7. PubMed ID: 1643252
[TBL] [Abstract][Full Text] [Related]
8. Formation of difluorothionoacetyl-protein adducts by S-(1,1,2,2-tetrafluoroethyl)-L-cysteine metabolites: nucleophilic catalysis of stable lysyl adduct formation by histidine and tyrosine.
Hayden PJ; Yang Y; Ward AJ; Dulik DM; McCann DJ; Stevens JL
Biochemistry; 1991 Jun; 30(24):5935-43. PubMed ID: 1904276
[TBL] [Abstract][Full Text] [Related]
9. Bioactivation of the cysteine-S-conjugate and mercapturic acid of tetrafluoroethylene to acylating reactive intermediates in the rat: dependence of activation and deactivation activities on acetyl coenzyme A availability.
Commandeur JN; De Kanter FJ; Vermeulen NP
Mol Pharmacol; 1989 Oct; 36(4):654-63. PubMed ID: 2811861
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic reaction of chlorotrifluoroethene with glutathione: 19F NMR evidence for stereochemical control of the reaction.
Dohn DR; Quebbemann AJ; Borch RF; Anders MW
Biochemistry; 1985 Sep; 24(19):5137-43. PubMed ID: 4074684
[TBL] [Abstract][Full Text] [Related]
11. Cysteine conjugate beta-lyase-catalyzed bioactivation of bromine-containing cysteine S-conjugates: stoichiometry and formation of 2,2-difluoro-3-halothiiranes.
Finkelstein MB; Dekant W; Anders MW
Chem Res Toxicol; 1996; 9(1):227-31. PubMed ID: 8924595
[TBL] [Abstract][Full Text] [Related]
12. Bioactivation mechanisms of haloalkene cysteine S-conjugates modeled by gas-phase, ion-molecule reactions.
Luu NC; Iyer RA; Anders MW; Ridge DP
Chem Res Toxicol; 2000 Jul; 13(7):610-5. PubMed ID: 10898593
[TBL] [Abstract][Full Text] [Related]
13. Characterization of thioether compounds formed from alkaline degradation products of enflurane.
Orhan H; Vermeulen NP; Sahin G; Commandeur JN
Anesthesiology; 2001 Jul; 95(1):165-75. PubMed ID: 11465554
[TBL] [Abstract][Full Text] [Related]
14. Bioactivation of S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteines and S-(trihalovinyl)-L-cysteines by cysteine S-conjugate beta-lyase: indications for formation of both thionoacylating species and thiiranes as reactive intermediates.
Commandeur JN; King LJ; Koymans L; Vermeulen NP
Chem Res Toxicol; 1996; 9(7):1092-102. PubMed ID: 8902263
[TBL] [Abstract][Full Text] [Related]
15. Glutathione-dependent bioactivation of haloalkenes.
Anders MW; Dekant W
Annu Rev Pharmacol Toxicol; 1998; 38():501-37. PubMed ID: 9597164
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites.
Anders MW; Lash L; Dekant W; Elfarra AA; Dohn DR
Crit Rev Toxicol; 1988; 18(4):311-41. PubMed ID: 3288445
[TBL] [Abstract][Full Text] [Related]
17. Renal cysteine conjugate beta-lyase. Bioactivation of nephrotoxic cysteine S-conjugates in mitochondrial outer membrane.
Lash LH; Elfarra AA; Anders MW
J Biol Chem; 1986 May; 261(13):5930-5. PubMed ID: 3700378
[TBL] [Abstract][Full Text] [Related]
18. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria.
Iyer RA; Anders MW
Anesthesiology; 1996 Dec; 85(6):1454-61. PubMed ID: 8968194
[TBL] [Abstract][Full Text] [Related]
19. Glutathione-dependent toxicity.
Anders MW; Dekant W; Vamvakas S
Xenobiotica; 1992; 22(9-10):1135-45. PubMed ID: 1441604
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of the nephrotoxic haloalkene 1,1,2-trichloro-3,3,3-trifluoro-1-propene by glutathione conjugation.
Vamvakas S; Kremling E; Dekant W
Biochem Pharmacol; 1989 Jul; 38(14):2297-304. PubMed ID: 2751695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
